Found 9945 bookmarks
Newest
A novel approach to correcting attribution of Clostridioides difficile in a healthcare setting - PubMed
A novel approach to correcting attribution of Clostridioides difficile in a healthcare setting - PubMed
The novel attribution metric shifts attribution from inpatient units to other settings and correlates modestly with NHSN methodology of attribution. If validated, the attribution metric may more accurately target C. difficile reduction efforts.
·pubmed.ncbi.nlm.nih.gov·
A novel approach to correcting attribution of Clostridioides difficile in a healthcare setting - PubMed
Co-Housing and Fecal Microbiota Transplantation: Technical Support for TCM Herbal Treatment of Extra-Intestinal Diseases Based on Gut Microbial Ecosystem Remodeling - PubMed
Co-Housing and Fecal Microbiota Transplantation: Technical Support for TCM Herbal Treatment of Extra-Intestinal Diseases Based on Gut Microbial Ecosystem Remodeling - PubMed
Dysregulation of the gut microbial ecosystem (GME) (eg, alterations in the gut microbiota, gut-derived metabolites, and gut barrier) may contribute to the onset and progression of extra-intestinal diseases. Previous studies have found that Traditional Chinese Medicine herbs (TCMs) play an important …
·pubmed.ncbi.nlm.nih.gov·
Co-Housing and Fecal Microbiota Transplantation: Technical Support for TCM Herbal Treatment of Extra-Intestinal Diseases Based on Gut Microbial Ecosystem Remodeling - PubMed
Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection - PubMed
Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection - PubMed
Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection
·pubmed.ncbi.nlm.nih.gov·
Efficacy and Practical Implementation of Fecal Microbiota Spores, Live-BRPK: A Novel Approach for Preventing Recurrent Clostridioides difficile Infection - PubMed
Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury - PubMed
Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury - PubMed
While fecal microbiota transplantation (FMT) shows promise in treating human diseases, oral capsule FMT is more accepted and accessible to patients. However, microbe selection in the upper gastrointestinal tract (UGIT) through oral administration remains unclear. Here, we demonstrate that short-term …
·pubmed.ncbi.nlm.nih.gov·
Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury - PubMed
Fecal virus transplantation has more moderate effect than fecal microbiota transplantation on changing gut microbial structure in broiler chickens - PubMed
Fecal virus transplantation has more moderate effect than fecal microbiota transplantation on changing gut microbial structure in broiler chickens - PubMed
Growing evidence of fecal microbiota transplantation (FMT) and fecal virus transplantation (FVT) provides a possibility to regulate animal health, whereas little is known about the impact of the 2 methods. This study aimed to investigate the effects of gut microbes on jejunal function in healthy bro …
·pubmed.ncbi.nlm.nih.gov·
Fecal virus transplantation has more moderate effect than fecal microbiota transplantation on changing gut microbial structure in broiler chickens - PubMed
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma - PubMed
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma - PubMed
Hepatocellular carcinoma (HCC) is a prevalent and aggressive liver malignancy. The interplay between bile acids (BAs) and the gut microbiota has emerged as a critical factor in HCC development and progression. Under normal conditions, BA metabolism is tightly regulated through a bidirectional interp …
·pubmed.ncbi.nlm.nih.gov·
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma - PubMed
Fecal Microbiota Transplantation Alleviates Severe PD-1 Inhibitor-Associated Colitis Caused by Neoadjuvant Therapy for Esophageal Cancer: A Case Report - PubMed
Fecal Microbiota Transplantation Alleviates Severe PD-1 Inhibitor-Associated Colitis Caused by Neoadjuvant Therapy for Esophageal Cancer: A Case Report - PubMed
Surgical resection is the preferred treatment for early-stage esophageal cancer. But most patients with esophageal cancer are diagnosed at advanced stages, making them ineligible for surgery. Therefore, preoperative neoadjuvant therapy has been introduced to help them meet surgical requirements. How …
·pubmed.ncbi.nlm.nih.gov·
Fecal Microbiota Transplantation Alleviates Severe PD-1 Inhibitor-Associated Colitis Caused by Neoadjuvant Therapy for Esophageal Cancer: A Case Report - PubMed
What Is the Ideal Duration for Surgical Antibiotic Prophylaxis? - PubMed
What Is the Ideal Duration for Surgical Antibiotic Prophylaxis? - PubMed
Background: Surgical antibiotic prophylaxis practice became common in the 1970s and has since become almost universal. The earliest articles used three doses over 12 hours with the first being administered before the start of the operation. Conclusions: The duration of pr …
·pubmed.ncbi.nlm.nih.gov·
What Is the Ideal Duration for Surgical Antibiotic Prophylaxis? - PubMed
Beyond Diet and Exercise: The Impact of Gut Microbiota on Control of Obesity - PubMed
Beyond Diet and Exercise: The Impact of Gut Microbiota on Control of Obesity - PubMed
Obesity, a widespread health concern characterized by the excessive accumulation of body fat, is a complex condition influenced by genetics, environment, and social determinants. Recent research has increasingly focused on the role of gut microbiota in obesity, highlighting its pivotal involvement i …
·pubmed.ncbi.nlm.nih.gov·
Beyond Diet and Exercise: The Impact of Gut Microbiota on Control of Obesity - PubMed
Outcomes of Clostridioides difficile infection In Acute Heart Failure Hospitalizations: Insights from the National Inpatient Database - PubMed
Outcomes of Clostridioides difficile infection In Acute Heart Failure Hospitalizations: Insights from the National Inpatient Database - PubMed
Heart failure (HF) patients are at a greater risk for nosocomial infections due to their higher prevalence of co-morbidities, readmission rates, and prolonged hospital stays. Clostridioides difficile infection (CDI) remains a common nosocomial infection in hospitalized patients. Limited information …
·pubmed.ncbi.nlm.nih.gov·
Outcomes of Clostridioides difficile infection In Acute Heart Failure Hospitalizations: Insights from the National Inpatient Database - PubMed
Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study - PubMed
Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study - PubMed
Haematopoietic stem cell transplantation (HSCT) is a curative approach for blood cancers, yet its efficacy is undermined by a range of acute and chronic complications. In light of mounting evidence to suggest that these complications are linked to a dysbiotic gut microbiome, we aimed to evaluate the …
·pubmed.ncbi.nlm.nih.gov·
Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study - PubMed
Gallic acid ameliorates colitis by trapping deleterious metabolite ammonia and improving gut microbiota dysbiosis - PubMed
Gallic acid ameliorates colitis by trapping deleterious metabolite ammonia and improving gut microbiota dysbiosis - PubMed
The dysbiosis of the gut microbiota and its metabolism directly cause the emergence of IBD. In this study, we aimed to clarify the anti-colitis mechanism of GA in sight of gut microbiota and its metabolite ammonia. We discovered that GA directly captured and reduced the harmful metabolite ammonia in …
·pubmed.ncbi.nlm.nih.gov·
Gallic acid ameliorates colitis by trapping deleterious metabolite ammonia and improving gut microbiota dysbiosis - PubMed
Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches - PubMed
Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches - PubMed
Clostridioides difficile infection (CDI) is a leading nosocomial infection, posing a substantial public health challenge within the United States and globally. CDI typically occurs in hospitalized elderly patients who have been administered antibiotics; however, there has been a rise in the o …
·pubmed.ncbi.nlm.nih.gov·
Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches - PubMed
The Microbiome in the Obesity-Breast Cancer Axis: Diagnostic and Therapeutic Potential - PubMed
The Microbiome in the Obesity-Breast Cancer Axis: Diagnostic and Therapeutic Potential - PubMed
A growing body of evidence has demonstrated a relationship between the microbiome, adiposity, and cancer development. The microbiome is emerging as an important factor in metabolic disease and cancer pathogenesis. This review aimed to highlight the role of the microbiome in obesity and its associati …
·pubmed.ncbi.nlm.nih.gov·
The Microbiome in the Obesity-Breast Cancer Axis: Diagnostic and Therapeutic Potential - PubMed
Next-Generation Sequencing-Based Monitoring of Intestinal Bacteria and Bacteriophages Following Fecal Microbiota Transplantation in Inflammatory Bowel Diseases - PubMed
Next-Generation Sequencing-Based Monitoring of Intestinal Bacteria and Bacteriophages Following Fecal Microbiota Transplantation in Inflammatory Bowel Diseases - PubMed
Inflammatory bowel diseases (IBD) and acute graft-versus-host disease (GVHD) are associated with persistent intestinal dysfunction preceded by gut bacterial dysbiosis. There are limited data on intestinal bacteriophages in these conditions. The aim of the present work was to detect associations betw …
·pubmed.ncbi.nlm.nih.gov·
Next-Generation Sequencing-Based Monitoring of Intestinal Bacteria and Bacteriophages Following Fecal Microbiota Transplantation in Inflammatory Bowel Diseases - PubMed
Application of Dominant Gut Microbiota Promises to Replace Fecal Microbiota Transplantation as a New Treatment for Alzheimer's Disease - PubMed
Application of Dominant Gut Microbiota Promises to Replace Fecal Microbiota Transplantation as a New Treatment for Alzheimer's Disease - PubMed
Several studies have confirmed that the pathophysiological progression of Alzheimer's disease (AD) is closely related to changes in the intestinal microbiota; thus, modifying the intestinal microbiota has emerged as a new way to treat AD. Effective interventions for gut microbiota include the applic …
·pubmed.ncbi.nlm.nih.gov·
Application of Dominant Gut Microbiota Promises to Replace Fecal Microbiota Transplantation as a New Treatment for Alzheimer's Disease - PubMed
Development of a Protocol for Anaerobic Preparation and Banking of Fecal Microbiota Transplantation Material: Evaluation of Bacterial Richness in the Cultivated Fraction - PubMed
Development of a Protocol for Anaerobic Preparation and Banking of Fecal Microbiota Transplantation Material: Evaluation of Bacterial Richness in the Cultivated Fraction - PubMed
Fecal microbiota transplantation (FMT) has shown highly variable results in indications beyond recurrent Clostridioides difficile infection. Microbiota dysbiosis in many diseases is characterized by the depletion of strictly anaerobic bacteria, which may be crucial for FMT efficacy. We develo …
·pubmed.ncbi.nlm.nih.gov·
Development of a Protocol for Anaerobic Preparation and Banking of Fecal Microbiota Transplantation Material: Evaluation of Bacterial Richness in the Cultivated Fraction - PubMed
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies - PubMed
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies - PubMed
Major depressive disorder (MDD) is a complex disorder and a leading cause of disability in 280 million people worldwide. Many environmental factors, such as microbes, drugs, and diet, are involved in the pathogenesis of depressive disorders. However, the underlying mechanisms of depression are compl …
·pubmed.ncbi.nlm.nih.gov·
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies - PubMed
The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis-A Literature Review - PubMed
The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis-A Literature Review - PubMed
Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon and rectum. UC's pathogenesis involves colonic epithelial cell abnormalities and mucosal barrier dysfunction, leading to recurrent mucosal inflammation. The purpose of the article is to show the complex interplay bet …
·pubmed.ncbi.nlm.nih.gov·
The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis-A Literature Review - PubMed
Modulating the Gut Microbiome in Multiple Sclerosis Management: A Systematic Review of Current Interventions - PubMed
Modulating the Gut Microbiome in Multiple Sclerosis Management: A Systematic Review of Current Interventions - PubMed
This review attempted to explore all recent clinical studies that have investigated the clinical and autoimmune impact of gut microbiota interventions in multiple sclerosis (MS), including dietary protocols, probiotics, fecal microbiota transplantation (FMT), and intermittent fasting (IF). Method …
·pubmed.ncbi.nlm.nih.gov·
Modulating the Gut Microbiome in Multiple Sclerosis Management: A Systematic Review of Current Interventions - PubMed
Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation - PubMed
Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation - PubMed
The efficacy of FMT for UC treatment was confirmed; however, the duration of remission varied substantially, possibly due to different characteristics of the initial microbiota of patients. Targeted analysis of a patient's microbiome before FMT could increase the treatment efficacy.
·pubmed.ncbi.nlm.nih.gov·
Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation - PubMed